ASIA News
The Singapore University of Social Sciences (SUSS) signed a Memorandum of Understanding (MOU) on February 23 with Changi General Hospital Pte Ltd (CGH) and SingHealth Community Hospitals (SCH) to collaborate on various initiatives to better understand and support the needs of the growing silver generation as well as their caregivers.
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.
Beijing-headquartered clinical genomics testing company, Berry Genomics and Hong Kong and London-headquartered genetics and digital health company Prenetics announced today key management hires for the new company, Circle DNA, which will be operational for business by the end of Q2 2019.
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million.
Accenture study finds millennials, Gen Z are looking to technology, nontraditional settings for hea…
Younger generations are less likely to have a primary care doctor. However, on the whole, virtual care and walk-in clinics are on the rise.
Digital therapeutics company Kaia Health has unveiled a feasibility study to examine the impact of its digital therapeutic treatment of Chronic Obstructive Pulmonary Disease (COPD) on Japan’s ageing population.
Yesterday, Merck, a German multinational pharmaceutical, chemical and life sciences company, and Tencent, a Chinese multinational investment holding conglomerate, signed a strategic collaboration agreement.
Ping An Good Doctor, a one-stop healthcare ecosystem platform from China, recently announced that their “Voiceprint Login System” (“Voiceprint Lock”), jointly developed with Unisound, an intelligent voice and language technology company in China, has achieved a login success rate close to 99%.
Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK’s patented sorbent technology.